Assignee
ALKAHEST INC
US24 patents
Top patents by PatentIndex Score
US10357513B2Jul 23, 2019
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC17 citations91
US11298377B2Apr 12, 2022
Methods of improving wound healing
ALKAHEST INC4 citations82
US10874692B2Dec 29, 2020
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC6 citations81
US10525107B2Jan 7, 2020
Blood plasma fractions as a treatment for aging-associated cognitive disorders
ALKAHEST INC12 citations81
US11103530B2Aug 31, 2021
Methods of improving or accelerating postoperative recovery
ALKAHEST INC7 citations80
US10905717B2Feb 2, 2021
Blood plasma and plasma fractions as therapy for tumor growth and progression
ALKAHEST INC5 citations79
US10245285B2Apr 2, 2019
Blood plasma and plasma fractions as therapy for tumor growth and progression
ALKAHEST INC11 citations79
US11484551B2Nov 1, 2022
Method of treating liver failure with plasma fraction IV-4
ALKAHEST INC2 citations71
US11413308B2Aug 16, 2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC1 citations70
US11547724B2Jan 10, 2023
Methods of treating a subject for pain
ALKAHEST INC1 citations68
US11439687B2Sep 13, 2022
Blood plasma fractions for use in muscle regeneration
ALKAHEST INC3 citations67
US10213421B2Feb 26, 2019
Pharmaceutical formulations comprising CCR3 antagonists
ALKAHEST INC5 citations62
US12053489B2Aug 6, 2024
Blood plasma fractions for use in liver regeneration
ALKAHEST INC0 citations60
US11951102B2Apr 9, 2024
Methods and compositions for treating retina-associated disease using CCR3-inhibitors
ALKAHEST INC1 citations60
US11660316B2May 30, 2023
Methods of inducing liver regeneration by administering a plasma protein fraction
ALKAHEST INC0 citations60
US11590118B2Feb 28, 2023
Methods and compositions for treating retina-associated disease using CCR3-inhibitors
ALKAHEST INC1 citations60
US11040068B2Jun 22, 2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC1 citations59
US12059453B2Aug 13, 2024
Blood plasma fractions for use in muscle regeneration
ALKAHEST INC0 citations57
US11426399B2Aug 30, 2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
ALKAHEST INC1 citations57
US11344542B2May 31, 2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
ALKAHEST INC0 citations57
US12496296B2Dec 16, 2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases
ALKAHEST INC0 citations54
US11957671B2Apr 16, 2024
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases
ALKAHEST INC1 citations54
US11612596B2Mar 28, 2023
Pharmaceutical formulations comprising CCR3 antagonists
ALKAHEST INC0 citations51
US11382907B2Jul 12, 2022
Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
ALKAHEST INC0 citations50